1. Home
  2. KXIN vs CVKD Comparison

KXIN vs CVKD Comparison

Compare KXIN & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KXIN
  • CVKD
  • Stock Information
  • Founded
  • KXIN 2015
  • CVKD 2022
  • Country
  • KXIN China
  • CVKD United States
  • Employees
  • KXIN N/A
  • CVKD N/A
  • Industry
  • KXIN Retail-Auto Dealers and Gas Stations
  • CVKD Medicinal Chemicals and Botanical Products
  • Sector
  • KXIN Consumer Discretionary
  • CVKD Health Care
  • Exchange
  • KXIN Nasdaq
  • CVKD Nasdaq
  • Market Cap
  • KXIN 9.2M
  • CVKD 8.2M
  • IPO Year
  • KXIN N/A
  • CVKD 2023
  • Fundamental
  • Price
  • KXIN $0.13
  • CVKD $0.46
  • Analyst Decision
  • KXIN
  • CVKD Strong Buy
  • Analyst Count
  • KXIN 0
  • CVKD 2
  • Target Price
  • KXIN N/A
  • CVKD $3.50
  • AVG Volume (30 Days)
  • KXIN 1.9M
  • CVKD 85.2K
  • Earning Date
  • KXIN 11-26-2019
  • CVKD 08-12-2024
  • Dividend Yield
  • KXIN N/A
  • CVKD N/A
  • EPS Growth
  • KXIN N/A
  • CVKD N/A
  • EPS
  • KXIN N/A
  • CVKD N/A
  • Revenue
  • KXIN $31,535,000.00
  • CVKD N/A
  • Revenue This Year
  • KXIN N/A
  • CVKD N/A
  • Revenue Next Year
  • KXIN N/A
  • CVKD N/A
  • P/E Ratio
  • KXIN N/A
  • CVKD N/A
  • Revenue Growth
  • KXIN N/A
  • CVKD N/A
  • 52 Week Low
  • KXIN $0.11
  • CVKD $0.36
  • 52 Week High
  • KXIN $5.52
  • CVKD $2.17
  • Technical
  • Relative Strength Index (RSI)
  • KXIN 42.66
  • CVKD 48.29
  • Support Level
  • KXIN $0.13
  • CVKD $0.43
  • Resistance Level
  • KXIN $0.16
  • CVKD $0.48
  • Average True Range (ATR)
  • KXIN 0.01
  • CVKD 0.03
  • MACD
  • KXIN -0.00
  • CVKD -0.00
  • Stochastic Oscillator
  • KXIN 10.81
  • CVKD 21.91

About KXIN Kaixin Auto Holdings

Kaixin Holdings is an auto retail platform for luxury used cars and imported new cars. The company is actively engaged in the research and development, design, manufacturing, and sales of electric vehicles and promotes the innovation of next-generation autonomous driving and artificial intelligence technologies. The company primarily generates revenues from sales of used cars, as well as fees obtained from its role as a channel partner for third-party auto financing and other value-added service providers.

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.

Share on Social Networks: